Niailah Ochai
Clinical Cardiac Electrophysiology · Sacramento, CANPI 1023508165
Payments from drug & device makers
What this record shows
This record is dominated by grants: $84,500 of the $94,925 with a category attached, or 89.0%. 18 manufacturers reported payments, led by Abbott at 52.8% of the total. Reporting peaked in 2024 at $65,502 and has fallen 61.6% since, to $25,138 in 2025.
Across 111 payments — averaging $855.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$50K
- Medtronic$37K
- Boston Scientific$5K
- Philips North America LLC$1K
- Biotronik Inc.$745
- Biosense Webster, Inc.$567
- plus $867 from 12 others
What the payments were for
- Grants$84,50089%
- Travel & lodging$4,3715%
- Food & beverage$5,0645%
- Education$9901%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 21 | $50,115 |
| Medtronic | 14 | $36,755 |
| Boston Scientific | 25 | $4,616 |
| Philips North America LLC | 7 | $1,261 |
| Biotronik Inc. | 7 | $745 |
| Biosense Webster, Inc. | 18 | $567 |
| Cordis US CORP. | 3 | $206 |
| Astellas Pharma US Inc | 2 | $167 |
| Medical Device Business Services, Inc. | 1 | $150 |
| Amgen | 3 | $150 |
| Cardiva Medical, Inc. | 2 | $61 |
| Abiomed | 2 | $41 |
| Tesaro, Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $17 |
| Edwards Lifesciences | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| AstraZeneca | 1 | $13 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$30,000
- ASSURITY$11,250
- TACTICATH$11,250
- Rhythmia Mapping System$1,073
- (9124) LM Undivided$622
- (9520) IGT Devices Undivided$452
- WATCHMAN Access System$436
- Acticor 7 VR-T DX$294
- ENSITE$267
- AMVIA EDGE$249
- ADVISA DR MRI SURESCAN$185
- Onyx$171
- Carto 3$150
- GENERAL - THERAPIES$144
- Repatha$124
- WATCHMAN FLX$119
- MYNX CONTROL VENOUS$100
How this compares
$94,925 in reported general payments places this provider in the 80th percentile of 290 clinical cardiac electrophysiology providers in California.
See all clinical cardiac electrophysiology providers in California →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 61 | $61,337 |
| Atorvastatin Calcium | 16 | $304 |
| Metoprolol Succinate | 30 | $278 |
| ClopidogrelClopidogrel Bisulfate | 17 | $169 |
| Losartan Potassium | 16 | $135 |
| Carvedilol | 16 | $94 |
| Furosemide | 16 | $84 |
| Cephalexin | 14 | $49 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Sacramento
- Arash AryanaSacramento$383K
- Mark BowersSacramento$125K
- Shephal DoshiSanta Monica$2.1M
- Jonathan HsuSan Diego$1.2M
- Leslie SaxonLos Angeles$1.1M
- Rahul BhardwajLoma Linda$935K
- Nicholas Olsonla Jolla$801K
- Jonathan DukesVentura$775K
- Brett GidneySanta Barbara$756K
- John Rogersla Jolla$738K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.